Table 1 Baseline Demographic and Clinical Data of Study Group.
From: Angiopoietin-2 predicts morbidity in adults with Fontan physiology
Fontan (n = 25) | Atrial Septal Defect (n = 12) | |
|---|---|---|
Age, y | 32.2 ± 9.1 | 28.6 ± 10.6 |
Male, n (%) | 10 (40) | 3 (25) |
Diagnosis, n (%) | ||
Atrial Septal Defect | 0 (0) | 12 (100) |
d-TGA | 5 (20) | 0 |
Double Outlet RV | 5 (20) | 0 |
Double Inlet LV | 4 (16) | 0 |
Tricuspid Atresia | 4 (16) | 0 |
Other | 7 (28) | 0 |
Fontan Type, n (%) | ||
Lateral Tunnel | 13 (52) | — |
Extracardiac | 8 (32) | — |
Atriopulmonary | 4 (16) | — |
Central Venous Pressure, mmHg | 15.3 ± 4.9 | 7.6 ± 3.2 |
Fontan Pressure, mmHg | 15.3 ± 5.0 | — |
Presence of AVM n (%) | 10 (40) | 0 |
History of PLE, n (%) | 1 (4) | 0 |
Clinical Ascites, n (%) | 8 (32) | 0 |
Liver Biopsy n (%) | ||
Normal | 2 (8) | — |
Fibrosis | 6 (24) | — |
Cirrhosis | 4 (16) | — |
Not Performed | 13 (52) | 12 |
Arrhythmia within 6 months, n (%) | 5 (20) | 0 |
History of Arrhythmia, n (%) | 18 (72) | 0 |
Atrial Flutter | 10 (56) | — |
Atrial Tachycardia | 5 (28) | — |
Other | 2 (16) | — |
